Assembly Biosciences's total assets for Q4 2025 were $257.59M, an increase of 7.33% from the previous quarter. ASMB total liabilities were $50.84M for the fiscal quarter, a -11.28% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.